Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer.

被引：5
|
作者：
Hofman, Michael
Violet, John A.
Hicks, Rodney J.
Ferdinandus, Justin
Thang, Sue Ping
Iravani, Amir
Kong, Grace
Kumar, Aravind Ravi
Akhurst, Timothy J.
Mooi, Jennifer
Guo, Christina
Tran, Ben
Jackson, Price
Scalzo, Mark
Eu, Peter
Williams, Scott
Sandhu, Shahneen Kaur
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Peter MacCallun Canc Ctr, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
228
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, Justin
    Eppard, Elisabeth
    Kuerpig, Stefan
    Gaertner, Florian
    Fimmers, Rolf
    Hauser, Stefan
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [22] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, J.
    Eppard, E.
    Kuerpig, S.
    Gaertner, F.
    Fimmers, R.
    Yordanova, A.
    Hauser, S.
    Essler, M.
    Feldmann, G.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S212 - S213
  • [23] EVALUATION OF RESPONSE TO 177LU-PSMA-617 BY SITE SPECIFIC DISEASE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Mahmoud, Ahmed M.
    Ahmed, Mohamed E.
    Abdelrazek, Ahmad
    Childs, Daniel
    Kendi, Ayse T.
    Johnson, Geoffrey
    Karnes, Jeffrey
    Kwon, Eugene
    Andrews, Jack
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1004 - E1004
  • [24] Impact of race on outcomes to 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC).
    Rami, Avina
    Ng, Thomas S. C.
    Rothmann, Emily
    Stoltenberg, Hailey
    Wolanski, Andrew
    Ritzer, Jolivette
    Choudhury, Atish Dipankar
    Gao, Xin
    Haberman, Veronica
    Kako, Bashar
    Kilbridge, Kerry L.
    Morgans, Alicia K.
    O'Shea, Aileen
    Taplin, Mary-Ellen
    Jacene, Heather
    Ravi, Praful
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 27 - 27
  • [25] Association of genomic alterations with clinical outcomes following lutetium-177-PSMA vipivotide tetraxetan in men with metastatic castrate-resistant prostate cancer.
    Gauntner, Timothy
    Gheeya, Jinesh S.
    Khorasanchi, Adam
    Xu, Menglin
    Hasanov, Elshad
    Collier, Katharine A.
    Meng, Lingbin
    Zimmerman, Danielle Elise
    Wang, Peng
    Folefac, Edmund
    Monk, Paul, III
    Mortazavi, Amir
    Clinton, Steven K.
    Yang, Yuanquan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] EVALUATION OF RESPONSE TO 177LU-PSMA-617 BY SITE SPECIFIC DISEASE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Mohamed, E. Ahmed
    Giuseppe, Reitano
    Ahmed, Mahmoud
    Umar, Ghaffar
    Tuba, Kendi Ayse
    Jeffrey, Karnes R.
    Eugene, Kwon
    Jack, Andrews
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [27] Patient outcomes after therapy with 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC): A tertiary center experience.
    Vaz, Nuno
    Ritzer, Jolivette
    Wolanski, Andrew
    Bhimaniya, Sudhir
    Choudhury, Atish Dipankar
    Hyun, Hyewon
    Kelly, Emma
    Kilbridge, Kerry L.
    Morgans, Alicia K.
    Pomerantz, Mark
    Robertson, Matthew
    Sakellis, Christopher
    Shah, Hina
    Sunkara, Rajitha
    Taplin, Mary-Ellen
    Wei, Xiao X.
    Whelpley, Bridget
    Ravi, Praful
    Jacene, Heather
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 87 - 87
  • [28] The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study
    Almuradova, Elvina
    Seyyar, Mustafa
    Arak, Haci
    Tamer, Fatih
    Kefeli, Umut
    Koca, Sinan
    Sen, Erdem
    Telli, Tugba Akin
    Karatas, Fatih
    Gokmen, Ivo
    Turhal, Nazim Serdar
    Sakalar, Teoman
    Ayhan, Murat
    Ekinci, Ferhat
    Hafizoglu, Emre
    Kahraman, Seda
    Kesen, Oguzhan
    Unal, Caglar
    Alan, Ozkan
    Celik, Serdar
    Yekeduz, Emre
    Omur, Ozgur
    Gokmen, Erhan
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (04) : 692 - 700
  • [29] Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial
    Ardolino, Luke C.
    Dear, Rachel
    Armstrong, Andrew J.
    Gillessen, Silke
    Joshua, Anthony M.
    EUROPEAN UROLOGY, 2023, 84 (04) : E94 - E95
  • [30] Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial
    Morris, Michael J.
    Sartor, Oliver
    de Bono, Johann S.
    Fizazi, Karim
    Tagawa, Scott T.
    EUROPEAN UROLOGY, 2023, 84 (01) : 7 - 8
12345